Full Spectrum CBD + CBG
500+mg CBD + 500+mg CBG extract 1 oz
WHAT IS CBG--in short it is another up and coming cannabinoid within the cannabis species.
Cannabigerol (CBG) is a non-psychoactive cannabinoid that plays an important role in the biochemistry of the cannabis plant. CBG displays a multitude of potential health benefits including working as a neuroprotectant, having antioxidant properties, aiding with skin ailments as an antibacterial and antifungal agent, appetite stimulation, treatment of gastrointestinal disorders, inflammation reduction, shows promise in fighting cancer, and lowering intraocular pressure, which may benefit glaucoma patients. CBG is anantibacterial, anti-tumor, and aids with insomnia. CBG is considered a ‘stem cell’ cannabinoid and can change into different cannabinoids, altering the overall effects of the plant. CBG, CBD, and the CBC’s all share the same molecular formula and weight, but have a different configuration.
CBG was examined for lowering intraocular pressure in a 1990 study, making it a possible glaucoma treatment. In a 2008 study CBG was found to be possibly beneficial in the treatment of MRSA due to its antibacterial and antifungal properties. A December 2014 study explored CBG as a possible agent to combat colorectal cancer. The neuroprotective properties of CBG were the subject of a January 2015 study, suggesting therapeutic potential for Huntington’s disease. CBG showed to be a particularly effective cannabinoid in a June 2015 study that focused on bladder dysfunction treatment options. An October 2016 study showed CBG to be potentially effective for inducing appetite.
References:
http://norml.org/library/item/introduction-to-the-endocannabinoid-system
https://www.ncbi.nlm.nih.gov/pubmed/1965836
https://pubs.acs.org/doi/full/10.1021/np8002673
https://www.ncbi.nlm.nih.gov/pubmed/25269802
https://www.ncbi.nlm.nih.gov/pubmed/25252936
https://www.ncbi.nlm.nih.gov/pubmed/26197538
https://www.ncbi.nlm.nih.gov/pubmed/275
WHAT IS CBG--in short it is another up and coming cannabinoid within the cannabis species.
Cannabigerol (CBG) is a non-psychoactive cannabinoid that plays an important role in the biochemistry of the cannabis plant. CBG displays a multitude of potential health benefits including working as a neuroprotectant, having antioxidant properties, aiding with skin ailments as an antibacterial and antifungal agent, appetite stimulation, treatment of gastrointestinal disorders, inflammation reduction, shows promise in fighting cancer, and lowering intraocular pressure, which may benefit glaucoma patients. CBG is anantibacterial, anti-tumor, and aids with insomnia. CBG is considered a ‘stem cell’ cannabinoid and can change into different cannabinoids, altering the overall effects of the plant. CBG, CBD, and the CBC’s all share the same molecular formula and weight, but have a different configuration.
CBG was examined for lowering intraocular pressure in a 1990 study, making it a possible glaucoma treatment. In a 2008 study CBG was found to be possibly beneficial in the treatment of MRSA due to its antibacterial and antifungal properties. A December 2014 study explored CBG as a possible agent to combat colorectal cancer. The neuroprotective properties of CBG were the subject of a January 2015 study, suggesting therapeutic potential for Huntington’s disease. CBG showed to be a particularly effective cannabinoid in a June 2015 study that focused on bladder dysfunction treatment options. An October 2016 study showed CBG to be potentially effective for inducing appetite.
References:
http://norml.org/library/item/introduction-to-the-endocannabinoid-system
https://www.ncbi.nlm.nih.gov/pubmed/1965836
https://pubs.acs.org/doi/full/10.1021/np8002673
https://www.ncbi.nlm.nih.gov/pubmed/25269802
https://www.ncbi.nlm.nih.gov/pubmed/25252936
https://www.ncbi.nlm.nih.gov/pubmed/26197538
https://www.ncbi.nlm.nih.gov/pubmed/275
